Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First Expedited NGS Test Breaks Through FDA Review

Dec 01 2017

• By Ferdous Al-Faruque

Related Content

Podcast: Thermo Fisher Talks Regulatory Experience With Oncomine

Jul 06 2017

'Breakthrough' Blueprint: US FDA Draft Guideline Outlines Revised Expedited Development Program

Oct 24 2017

A New York Minute: US FDA Leverages State's Health Department To Expedite NGS Reviews

Nov 15 2017

Foundation Medicine Seeks "Go-To" Companion Diagnostic Status For Sequencing Test

Jun 20 2011

Multi-Companion Profiling Assay Enters FDA, CMS Express Lanes

Aug 03 2016

FDA Extends Parallel Review Program ‘Indefinitely’

Oct 21 2016

Related Companies

Foundation Medicine, Inc.

Exact Sciences Corp.

Thermo Fisher Scientific

Memorial Sloan Kettering Cancer Center

Additional Topics

United States Regulation Reimbursement Approvals Personalized Medicine Cancer In Vitro Diagnostics Medical Device

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window